Metabolic management of ischaemic heart disease

S. L. Chierchia, G. Fragasso

Research output: Contribution to journalArticlepeer-review


The present review summarizes the available information on the effects of the three major classes of antianginal agents (nitrates, calcium and beta-blockers) on myocardial energy metabolism. It also discusses the role of some new molecules (L-carnitine trimetazidine and ranolazine) that have been proposed as an alternative pharmacological approach for the metabolic management of cardiac ischaemic syndromes.

Original languageEnglish
Pages (from-to)2-5
Number of pages4
JournalEuropean Heart Journal
Issue numberSUPPL. G
Publication statusPublished - 1993


  • Antianginal drugs
  • Cardiac metabolism
  • Ischaemic heart disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Metabolic management of ischaemic heart disease'. Together they form a unique fingerprint.

Cite this